Barclays PLC 6-K, filed Feb 2, 2021
Barclays PLC (BCS)
6-K
2021-02-02
For: 2021-02-01
View Original
Added on
April 11, 2026
About this 6-K
Barclays PLC filed this 6-K on February 2, 2021.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13A-16 OR 15D-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
February
02, 2021
Barclays PLC
(Name
of Registrant)
1 Churchill Place
London E14 5HP
England
(Address
of Principal Executive Office)
Indicate
by check mark whether the registrant files or will file annual
reports
under
cover of Form 20-F or Form 40-F.
Form
20-F x Form 40-F
Indicate
by check mark whether the registrant by furnishing the
information
contained
in this Form is also thereby furnishing the information to
the
Commission
pursuant to Rule 12g3-2(b) under the Securities Exchange Act of
1934.
Yes No
x
If
"Yes" is marked, indicate below the file number assigned to the
registrant
in
connection with Rule 12g3-2(b):
This
Report on Form 6-K is filed by Barclays PLC.
This
Report comprises:
Information
given to The London Stock Exchange and furnished pursuant
to
General
Instruction B to the General Instructions to Form 6-K.
EXHIBIT
INDEX
|
Exhibit
No. 1
|
Total
Voting Rights dated 04 January 2021
|
|
Exhibit
No. 2
|
Publication
of Pricing Supplement dated 07 January 2021
|
|
Exhibit
No. 3
|
Block
listing Interim Review dated 13 January 2021
|
|
Exhibit
No. 4
|
Notice
to Holders of Results of Adjourned Meeting dated 15 January
2021
|
|
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
|
BARCLAYS
PLC
|
|
|
(Registrant)
|
Date:
February 02, 2021
|
|
By: /s/
Karen Rowe
--------------------------------
|
|
|
Karen
Rowe
|
|
|
Assistant
Secretary
|
|
|
Exhibit
No. 1
4 January 2021
Barclays PLC - Total Voting Rights
In accordance with the Financial Conduct Authority's (FCA)
Disclosure Guidance and Transparency Rule 5.6.1R, Barclays PLC
notifies the market that as of 31 December 2020, Barclays PLC's
issued share capital consists of 17,359,296,032 Ordinary shares
with voting rights.
There are no Ordinary shares held in Treasury.
The above figure (17,359,296,032)
may be used by shareholders (and others with notification
obligations) as the denominator for the calculation by which they
will determine if they are required to notify their interest in, or
a change to their interest in, Barclays PLC under the FCA's
Disclosure Guidance and Transparency
Rules.
- Ends -
For further information, please contact:
|
Investor Relations
|
Media Relations
|
|
Chris
Manners
|
Tom
Hoskin
|
|
+44 (0)20 7773 2136
|
+44
(0)20 7116 4755
|
Exhibit
No. 2
Publication of Pricing Supplement
The following pricing supplement (the "Pricing
Supplement") is available for
viewing:
Pricing Supplement in relation to Barclays PLC's issue of USD
500,000,000 Zero Coupon Callable Notes due 2051 under the Barclays
PLC £60,000,000,000 Debt Issuance Programme.
Please read the disclaimer below "Disclaimer - Intended
Addressees" before attempting
to access this service, as your right to do so is conditional upon
complying with the requirements set out below.
To view the full document, please paste the following URL into the
address bar of your browser.
http://www.rns-pdf.londonstockexchange.com/rns/9898K_1-2021-1-7.pdf
A copy of the Pricing Supplement has been submitted to the National
Storage Mechanism and will shortly be available for inspection
at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism
For further information, please contact:
Barclays Treasury
1 Churchill Place
Canary Wharf
London E14 5HP
DISCLAIMER - INTENDED ADDRESSEES
IMPORTANT: You must read the following
before continuing: The
following applies to the Pricing Supplement available by clicking
on the link above, and you are therefore advised to read this
carefully before reading, accessing or making any other use of the
Pricing Supplement. In accessing the Pricing Supplement, you agree
to be bound by the following terms and conditions, including any
modifications to them, any time you receive any information from us
as a result of such access.
The Pricing Supplement referred to above must be read in
conjunction with the base prospectus dated 25 February 2020 and the
supplemental base prospectuses dated 30 April 2020, 30 July 2020
and 26 October 2020, which together constitute a base prospectus
(the "Prospectus").
THE PRICING SUPPLEMENT MAY NOT BE FORWARDED OR DISTRIBUTED OTHER
THAN AS PROVIDED BELOW AND MAY NOT BE REPRODUCED IN ANY MANNER
WHATSOEVER. THE PRICING SUPPLEMENT MAY ONLY BE DISTRIBUTED OUTSIDE
THE UNITED STATES TO PERSONS THAT ARE NOT U.S. PERSONS AS DEFINED
IN, AND IN RELIANCE ON, REGULATION S UNDER THE U.S. SECURITIES ACT
OF 1933, AS AMENDED (THE "SECURITIES
ACT"). ANY FORWARDING,
DISTRIBUTION OR REPRODUCTION OF THE PRICING SUPPLEMENT IN WHOLE OR
IN PART IS PROHIBITED. FAILURE TO COMPLY WITH THIS NOTICE MAY
RESULT IN A VIOLATION OF THE SECURITIES ACT OR THE APPLICABLE LAWS
OF OTHER JURISDICTIONS.
NOTHING IN THIS ELECTRONIC PUBLICATION CONSTITUTES AN OFFER OF
SECURITIES FOR SALE IN ANY JURISDICTION. ANY NOTES ISSUED OR TO BE
ISSUED PURSUANT TO THE PRICING SUPPLEMENT AND THE PROSPECTUS HAVE
NOT BEEN, AND WILL NOT BE, REGISTERED UNDER THE SECURITIES ACT OR
THE SECURITIES LAWS OF ANY STATE OF THE UNITED STATES OR OTHER
JURISDICTION. ANY NOTES ISSUED OR TO BE ISSUED PURSUANT TO THE
PRICING SUPPLEMENT AND THE PROSPECTUS MAY NOT BE OFFERED, SOLD,
PLEDGED OR OTHERWISE TRANSFERRED EXCEPT IN AN OFFSHORE TRANSACTION
TO A PERSON THAT IS NOT A U.S. PERSON IN ACCORDANCE WITH RULE 903
OR RULE 904 OF REGULATION S UNDER THE SECURITIES ACT.
Please note that the information contained in the Pricing
Supplement and the Prospectus referred to above may be addressed to
and/or targeted at persons who are residents of particular
countries (specified in the Pricing Supplement and/or the
Prospectus) only and is not intended for use and should not be
relied upon by any person outside these countries and/or to whom
the offer contained in the Pricing Supplement and/or the Prospectus
is not addressed. Prior to relying on the
information contained in the Pricing Supplement and/or the
Prospectus you must ascertain from the Pricing Supplement and the
Prospectus whether or not you are part of the intended addressees
of the information contained therein.
Confirmation of your Representation: In order to be eligible to view the Pricing
Supplement or make an investment decision with respect to any Notes
issued or to be issued pursuant to the Pricing Supplement, you must
be a person other than a U.S. person (within the meaning of
Regulation S under the Securities Act). By accessing the Pricing
Supplement, you shall be deemed to have represented that you are
not a U.S. person, and that you consent to delivery of the Pricing
Supplement via electronic publication.
You are reminded that the Pricing Supplement has been made
available to you on the basis that you are a person into whose
possession the Pricing Supplement may be lawfully delivered in
accordance with the laws of the jurisdiction in which you are
located and you may not, nor are you authorised to, deliver the
Pricing Supplement to any other person.
The Pricing Supplement does not constitute, and may not be used in
connection with, an offer or solicitation in any place where offers
or solicitations are not permitted by law. If a jurisdiction
requires that the offering be made by a licensed broker or dealer
and the underwriters or any affiliate of the underwriters is a
licensed broker or dealer in that jurisdiction, the offering shall
be deemed to be made by the underwriters or such affiliate on
behalf of the issuer in such jurisdiction. Under no
circumstances shall the Pricing Supplement constitute an
offer to sell, or the solicitation of an offer to buy, nor shall
there be any sale of any Notes issued or to be issued pursuant
to the Pricing Supplement, in any jurisdiction in which such
offer, solicitation or sale would be unlawful.
The Pricing Supplement has been made available to you in an
electronic form. You are reminded that documents transmitted via
this medium may be altered or changed during the process of
electronic transmission and consequently none of the issuer, its
advisers nor any person who controls any of them nor any director,
officer, employee nor agent of it or affiliate of any such person
accepts any liability or responsibility whatsoever in respect of
any difference between the Pricing Supplement made available to you
in electronic format and the hard copy version available to you on
request from the issuer.
Your right to access this service is conditional upon complying
with the above requirement.
Exhibit No.
3
BLOCK LISTING SIX MONTHLY RETURN
Date: 13 January
2021
|
Name of applicant:
|
BARCLAYS
PLC
|
|||
|
Period of return:
|
From 1
July 2020 - 31 December 2020
|
|||
|
Name of scheme:
|
SAYE
Share Option Scheme
|
Barclays
Group Share Incentive Plan
|
Barclays
Group Share Value Plan
|
Barclays
Long Term Incentive Plan
|
|
Class of unallotted securities
|
Ordinary
shares of 0.25p each
|
Ordinary
shares of 0.25p each
|
Ordinary
shares of 0.25p each
|
Ordinary
shares of 0.25p each
|
|
Balance of unallotted securities under scheme(s) from previous
return:
|
37,041,940
|
5,382,681
|
431,619
|
22,355,858
|
|
Plus: The amount
by which the block scheme(s) has been increased since the date of
the last return (if any increase has been applied
for):
|
0
|
40,000,000
|
0
|
0
|
|
Less: Number
of securities issued/allotted under
scheme(s) during period (see LR3.5.7G):
|
169,464
|
13,699,851
|
0
|
700,794
|
|
Equals: Balance
under scheme(s) not yet issued/allotted at end of
period:
|
36,872,476
|
31,682,830
|
431,619
|
21,655,064
|
|
Name of contact:
|
Garth
Wright
|
|||
|
Telephone number of contact:
|
020
7116 3170
|
|||
Exhibit
No. 4
FOR DISTRIBUTION ONLY OUTSIDE THE UNITED STATES TO PERSONS OTHER
THAN "U.S. PERSONS" (AS DEFINED IN REGULATION S OF THE UNITED
STATES SECURITIES ACT OF 1933, AS AMENDED). NOT FOR RELEASE,
PUBLICATION OR DISTRIBUTION IN OR INTO, OR TO ANY PERSON LOCATED OR
RESIDENT IN, ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO
RELEASE, PUBLISH OR DISTRIBUTE THIS DOCUMENT.
THIS NOTICE IS IMPORTANT AND REQUIRES THE IMMEDIATE ATTENTION OF
HOLDERS.
BARCLAYS PLC
(Incorporated with limited liability in England and Wales,
registered number 00048839)
(the "Issuer")
NOTICE TO HOLDERS OF RESULT OF ADJOURNED MEETING
U.S.$1,500,000,000 7.875 per cent. Fixed Rate Resetting Perpetual
Subordinated Contingent Convertible Securities (Callable 2022 and
Every Five Years Thereafter) ISIN: XS1481041587
(the "Securities")
NOTICE IS HEREBY GIVEN to the Holders of the Securities that, at
the adjourned Meeting of Holders held on 15 January 2021, the
respective Extraordinary Resolution set out in the Notice of
Adjourned Meetings previously notified to Holders in accordance
with the terms of the relevant Trust Deed was passed but the
Eligibility Condition was not satisfied. Accordingly, the
modifications referred to in the respective Extraordinary
Resolution will not be implemented. Unless the context otherwise
requires, capitalised terms used but not defined in this Notice
shall have the meaning given in the Consent Solicitation Memorandum
dated 23 November 2020 (the "Consent Solicitation
Memorandum").
For further information Holders should contact Lucid Issuer
Services Limited (Attention: Arlind Bytyqi, Telephone: +44 20 7704
0880, Email: barclays@lucid-is.com)
This Notice is given by:
BARCLAYS PLC
Dated 15 January 2021
DISCLAIMER: This
announcement must be read in conjunction with the Consent
Solicitation Memorandum. If any Holder is in any doubt as to the
action it should take or is unsure of the impact of the lack of
implementation of the relevant Extraordinary Resolution, it is
recommended to seek its own financial and legal advice, including
in respect of any tax consequences, immediately from its broker,
bank manager, solicitor, accountant or other independent financial,
tax or legal adviser. None of the Issuer, the Solicitation
Agent, the Tabulation Agent, the Trustee, the Registrar or the
Principal Paying Agent expresses any opinion about the terms of the
Extraordinary Resolution.
Nothing in this announcement or the Consent Solicitation Memorandum
constitutes or contemplates an offer of, an offer to purchase or
the solicitation of an offer to purchase or sell any security in
any jurisdiction. The distribution of this announcement and the
Consent Solicitation Memorandum in certain jurisdictions may be
restricted by law, and persons into whose possession this
announcement or the Consent Solicitation Memorandum comes are
requested to inform themselves about, and to observe, any such
restrictions.